CARISOPRODOL
These highlights do not include all the information needed to use C arisoprodol Tablets USP safely and effectively. See full prescribing information for carisoprodol . C arisoprodol Tablets for Oral use Initial U.S. Approval: 1959
Approved
Approval ID
c4a6a7e6-e49b-4202-b9d3-62c76a13b106
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 31, 2012
Manufacturers
FDA
Life Line Home Care Services, Inc
DUNS: 844985374
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CARISOPRODOL
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code75921-513
Application NumberANDA087499
Product Classification
M
Marketing Category
C73584
G
Generic Name
CARISOPRODOL
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 31, 2012
FDA Product Classification
INGREDIENTS (8)
CARISOPRODOLActive
Quantity: 350 mg in 1 1
Code: 21925K482H
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
DOCUSATE SODIUMInactive
Code: F05Q2T2JA0
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT